Rectal Cancer Treatment Algorithm - Multidisciplinary Approach with Drs. Madhu Eluri & Nina Sanford
From Oncology Brothers: Practice-Changing Cancer Discussions · · 19 min
This plays from the publisher's own server. We do not host a copy.
Description
In this segment of the treatment algorithms, we focused on rectal cancer treatment landscape with Dr. Nina Sanford, a radiation oncologist, and Dr. Madhu Eluri, MD, a medical oncologist.
In this episode, we discussed:
- The recent approval of dostarlimab for MSI-high rectal cancer and its implications for treatment
- The importance of a multidisciplinary approach in managing stage II and III rectal cancer
- The debate between total neoadjuvant treatment (TNT) versus the PROSPECT trial approach
- The role of chemotherapy, radiation, and surgery in various risk categories of rectal cancer
- How to monitor patients post-treatment and the significance of circulating tumor DNA (ctDNA) in decision-making
- Insights into the management of metastatic rectal cancer and the potential for organ preservation
Tune in for a comprehensive discussion that emphasizes the importance of biomarker-driven care and the evolving landscape of rectal cancer treatment.
Listen us on:
Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o
Follow us on social media:
• X/Twitter: https://x.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Don't forget to like, subscribe, and hit the notification bell for more episodes from the Oncology Brothers!
#RectalCancer, #MultiD, #MSI-H, #TNT, #OncologyBrothers
Back to Oncology Brothers: Practice-Changing Cancer Discussions · Report a problem